收藏商品
全国免费服务热线
4000-520-616
BETbromodomaininhibitor.DownregulatesMycexpression,causesG1cellcyclearrestandattenuatescellproliferationinhumanpancreaticneuroendocrinetumors.ArreststhegrowthofTcellacutelymphoblasticleukemiacellsinvitro(EC50=91.2nM).Alsoenhancestheantitumoreffectofrapamycin(Cat.No.1292)invitroandattenuatesrapamycininducedAktactivation.Orallybioavailable.
CPI203isalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight399.9.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Wongetal(2014)Thebromodomainandextra-terminalinhibitorCPI203enhancestheantiproliferativeeffectsofrapamycinonhumanneuroendocrinetumors.CellDeathDis.5e1450PMID:25299775
Kingetal(2013)TheubiquitinligaseFBXW7modulatesleukemia-initiatingcellactivitybyregulatingMYCstABIlity.Cell1531552PMID:23791182
Keywords:CPI203,supplier,CPI203,BET,BRD4,domain,inhibitors,inhibits,(+)-JQ1,analogue,analog,4499,Myc,G1,cell,cycle,arrest,antitumor,rapamycin,AKT,Bromodomains,Cell,Cycle,Inhibitors,Bromodomains,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10